Gene expression profiling in Venous thromboembolism: Insights from publicly available datasets

Sunanda Arya1, Rashi Khare1, Iti Garg1

  • 1Defence Institute of Physiology and Allied Sciences (DIPAS), Defence Research and Development Organization (DRDO), Lucknow Road, Timarpur, Delhi 110054, India.

PubMed

Insights

Venous thromboembolism (VTE) involves complex genetic factors. This study identified key up-regulated genes like MYC and down-regulated genes like MRPL13, offering insights for new diagnostic and therapeutic strategies.

Area of Science:

  • Genomics and Bioinformatics
  • Cardiovascular Disease Research
  • Molecular Biology

Background:

  • Venous thromboembolism (VTE) is a significant global health issue, ranking as the third leading cause of cardiovascular disease.
  • The intricate genetic underpinnings of VTE pathogenesis remain incompletely understood, necessitating further investigation.

Purpose of the Study:

  • To identify critical hub genes and molecular pathways implicated in the development and progression of VTE.
  • To leverage public gene expression data for a comprehensive analysis of VTE-associated genetic mechanisms.

Main Methods:

  • Differential gene expression (DEG) analysis was performed on two VTE patient datasets (GSE48000 and GSE19151) using the GEO2R tool.
  • Bioinformatics tools were employed to compare gene expression profiles between VTE patients and healthy controls.
  • Protein-protein interaction (PPI) network analysis was utilized to identify key hub genes.

Main Results:

  • Analysis revealed 19 up-regulated and 134 down-regulated genes in VTE patients.
  • Significantly enriched pathways included complement and coagulation cascade, B-cell receptor signaling, DNA methylation, and inflammation.
  • Top up-regulated hub genes (MYC, FOS, SGK1, CR2, CXCR4) are linked to vascular integrity, while down-regulated hub genes (MRPL13, MRPL3, MRPL11, RPS29, RPL9) are primarily mitochondrial ribosomal proteins.

Conclusions:

  • This study elucidates significantly enriched pathways and genes crucial for VTE development and prognosis.
  • The identified genetic markers and pathways hold potential for the development of novel diagnostic and therapeutic interventions for VTE management.
Abstract